PRODUCT LITERATURE

Multicenter nonrandomized trial of ramosetron versus palonosetron in controlling chemotherapy-induced nausea and vomiting for colorectal cancer

---

Chemotherapy-induced nausea and vomiting (CINV) have a negative impact on patients’ quality of life and
frequently pointed to as a major factor for treatment abandonment. Serotonin (5-HT3) receptor antagonist is considered
as key treatment for CINV. Ramosetron and palonosetron are recently developed 5-HT3 receptor antagonists and known
as more superior than other first-generation 5-HT3 receptor antagonists. The purpose of this study was to compare the
efficacy of ramosetron and palonosetron and determine which drug is more effective for prevention of CINV.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

LITERATURE

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Colorectal Cancer
Palofer
Controlling chemotherapy-induced nausea

Specific Detail Info

-

Statement of Responsibility

Ann Surg Treat Res 2014;87(1):9-13

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment